25 Jan 2022 Cingulate Appoints Curt Medeiros and Gregg Givens to Board of Directors
Enhances Board’s Expertise in Finance, Healthcare Technology, and Market Access Strategies KANSAS CITY, Kan., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Following its initial public offering last month, Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary